| DC Field | Value | Language |
|---|
| dc.contributor.author | Dorofeeva, S. G. | - |
| dc.contributor.author | Konoplya, E. N. | - |
| dc.contributor.author | Mansimova, O. V. | - |
| dc.date.accessioned | 2025-11-17T08:47:07Z | - |
| dc.date.available | 2025-11-17T08:47:07Z | - |
| dc.date.issued | 2025 | - |
| dc.identifier.citation | Dorofeeva, S.G. Correction of protein and lipid spectra of erythrocyte membranes as a pathogenetic supplement to the therapy of coronary heart disease / S.G. Dorofeeva, E.N. Konoplya, O.V. Mansimova // Research Results in Pharmacology. - 2025. - Vol.11, №3.-P. 1-9. - Doi: 10.18413/rrpharmacology.11.718. - Refer.: p. 8. | ru |
| dc.identifier.uri | http://dspace.bsuedu.ru/handle/123456789/65885 | - |
| dc.description.abstract | The drug Mexicor, which has antioxidant and endothelioprotective properties, is able to suppress oxidative stress and, therefore, restore the biochemical structure and gas exchange function of erythrocyte membranes, which can significantly complement traditional systems of therapy for cardiovascular diseases and CHD in particular | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | pharmacology | ru |
| dc.subject | oxidative stress | ru |
| dc.subject | cardiovascular diseases | ru |
| dc.subject | clinical trial | ru |
| dc.subject | Mexicor | ru |
| dc.subject | antioxidant | ru |
| dc.title | Correction of protein and lipid spectra of erythrocyte membranes as a pathogenetic supplement to the therapy of coronary heart disease | ru |
| dc.type | Article | ru |
| Appears in Collections: | Vol. 11, № 3
|
